Results 81 to 90 of about 4,284 (156)

Assessment of disease activity in Graves' orbitopathy. [PDF]

Front Ophthalmol (Lausanne)
Potvin ARGG, Lacraru IC, Bisschop PH, de Win MML, Eckstein AK, Saeed P.   +5 more
europepmc   +1 more source

Unravelling the pathogenic mechanisms in Graves' orbitopathy. [PDF]

Eur Thyroid J
Lee ACH, Kahaly GJ.
europepmc   +1 more source

Sarilumab in the management of Graves orbitopathy with low clinical activity scores. [PDF]

Sci Rep
Pérez-Moreiras J, Abelenda D, Providência J, Castela G.   +3 more
europepmc   +1 more source

Correction: Role of the suppressor of cytokine signaling-3 in the pathogenesis of Graves' orbitopathy. [PDF]

Front Endocrinol (Lausanne)
Kim W, Seo MK, Kim YJ, Choi SH, Ku CR, Kim S, Lee EJ, Yoon JS.   +7 more
europepmc   +1 more source

Extracellular vesicles in Graves' disease and Graves' orbitopathy: immunoregulatory mechanisms, biomarkers, and therapeutic potentials. [PDF]

Front Immunol
Chen Y, Yang Y, Yang S, Yuan W, Jiang L, Wei R.   +5 more
europepmc   +1 more source

Modulation of gut microbiota in Graves' orbitopathy: Prevotella dominance and atorvastatin's impact. [PDF]

Microbiome
Wang D, Chen Y, Yang J, Zhang Y, Deng X, Liu Y, Chen Y, Yang X, Wang X, Liang C, Xie Q, Hao Y, Yuan H.   +12 more
europepmc   +1 more source

The impact of graves' orbitopathy on anterior segment structures and choroidal parameters. [PDF]

BMC Ophthalmol
Sevimli N, Eryılmaz M, Azarbaz MK, Taydaş G.   +3 more
europepmc   +1 more source

Pediatric Graves' orbitopathy: TRAb and FT-3 are also prognostic factors in children-A tertiary center study. [PDF]

Thyroid Res
Al-Ghazzawi K, Oeverhaus M, Rama A, Kiewert C, Bechrakis N, Chen Y, Neumann I, Eckstein A.   +7 more
europepmc   +1 more source

Higher serum IgG4 levels correlate with better quality of life in mild Graves' orbitopathy: a preliminary report. [PDF]

Endocr Connect
Lin CH, Lee YC, Hsiue YC, Wei YH, Lee CW, Yang CY, Fan KC, Yen IW, Lu C, Huang TY, Lin CH, Shih SR.   +11 more
europepmc   +1 more source

Comparison of the 2021 EUGOGO guidelines and the 2022 ATA/ETA consensus statement for the management of Graves' orbitopathy. [PDF]

Eur Thyroid J
Bartalena L, Gallo D, Kahaly GJ, Marinò M, Tanda ML.   +4 more
europepmc   +1 more source